Market Overview

Global Biosimilars Market Report 2020: Market Revenue Forecast for the Third-Wave Biosimilars Market, 2020-2026

Share:

Dublin, Nov. 16, 2020 (GLOBE NEWSWIRE) -- The "Global Biosimilars Market 2020-2026: Access to New Therapy Areas to Drive Major Growth" report has been added to ResearchAndMarkets.com's offering.

This research service provides critical insights into the global biosimilar industry, highlighting the key growth opportunities, market revenue forecasts, and trends that will influence the industry with the emergence of the third wave of biosimilars.

The global third-wave biosimilars market covered in this study includes a discussion of antibody therapies and recombinant proteins. It also includes a market forecast for the third wave biosimilars till 2026, capturing the interesting developments and market dynamic shifts that are set to influence the growth of industry stakeholders.

This study identifies the largest revenue-generating therapeutic areas and drug types, and the year with the highest market revenue potential for biosimilar companies based on biologics patent expiry. Market entry considerations for biosimilar companies and factors influencing global biosimilar penetration have been clearly outlined. This research service also provides comprehensive insights on the complex dynamics that are set to influence the third wave of biosimilars, such as the re-imbursement and the payer landscape, biosimilar pricing trends, and the various sales models that are prevalent in the biosimilars industry.

Regional differences in terms of biosimilar pricing have also been discussed in this study in addition to the challenges relevant to the industry such as physicians' acceptance of biosimilars, manufacturing complexities, and patent litigations. Most importantly, this study highlights the competitive landscape for the third wave of biosimilars, providing the different approaches taken by innovator companies to fight biosimilar competition.

Finally, the study delineates the key growth opportunities that can help increased biosimilar uptake, overcome manufacturing complexities, handle biobetter innovations, and leverage advantages in competing for newer therapy areas, such as ophthalmology.

Research Highlights

  • Market revenue forecast for the third-wave biosimilars market, 2020-2026
  • Segment-wise revenue forecast by therapeutic area and drug type
  • Competitive landscape analysis of the third-wave biosimilars market
  • Market dynamics influencing the third-wave biosimilars market
  • Growth opportunities in the global biosimilars market
  • Strategic imperatives for the global biosimilars market

Key Issues Addressed

  • What will be the market revenue of the global third-wave biosimilars market from 2020 to 2026?
  • Which therapy areas and patent expiry years of biologics are likely to influence this market?
  • What are the key trends that will influence the industry during the forecast period?
  • How does the third-wave biosimilars competitive landscape look like?
  • What are the major growth opportunities in the global biosimilars industry?

Key Topics Covered:

1. Strategic Imperatives

  • Why Is It Increasingly Difficult to Grow?
  • The Strategic Imperative
  • Strategic Imperatives for the Global Biosimilars Industry
  • Growth Opportunities Fuel the Growth Pipeline EngineT

2. Growth Opportunity Analysis - Global Biosimilars Market

  • Scope of Analysis
  • Biosimilars in the Perspective of Regulatory Bodies
  • Key Differences between Biosimilars, Biologics, and Biobetters
  • Focus of Study: The Third Wave of Biosimilars
  • Market Segmentation by Product
  • Key Competitors in the Global Biosimilars Market
  • Key Growth Metrics for the Third-wave Biosimilars Market
  • Distribution Channels Adopted by Biosimilar Companies
  • Market Entry Considerations for Biosimilars
  • Factors Affecting Global Penetration of Biosimilars
  • 4 Key Developments in the Re-imbursement and Payer Landscape
  • Regulatory Changes That Have Influenced The Biosimilar Market
  • Growth Drivers for the Global Biosimilars Market
  • Growth Restraints for Global Biosimilars Market
  • Forecast Methodology and Assumptions - Third-wave Biosimilars Market
  • Total Third-wave Biosimilars Market
  • Market Forecast Analysis, 2020-2026 (Total Third-wave Biosimilars Market)
  • Forecast by Drug Type: Antibody Therapies vs. Recombinant Proteins
  • Market Forecast Analysis, 2020-2026 (by Drug Type)
  • Forecast by Therapy Area - Third-wave Biosimilars Market
  • Forecast of Third-wave Biosimilars - By Year-wise Patent-expiry of Biologics
  • Market Forecast Analysis, 2020-2026 (By Therapy Area and Year-wise patent expiry of Biologics)
  • Regional Analysis - Global Biosimilars Market
  • Regional Analysis of Factors Impacting Biosimilars Market Access
  • Regional Analysis Discussion
  • Pricing Trends - US Biosimilars Market
  • Pricing Trends - Western Europe Biosimilars Market
  • Competitive Environment - Global Biosimilars Market
  • Companies to Action
  • Impact of Third-wave Biosimilars on the Competitive Landscape
  • Case Study: AbbVie - Delaying Biosimilar Competition

3. Growth Opportunity Universe, 2020

  • Major Growth Opportunities
  • Growth Opportunity 1: Manufacturing Outsourcing Collaborations for Complex Third-wave Biosimilars, 2020
  • Growth Opportunity 2: Increased Market Access Through Biobetter Innovations For Biosimilar Companies, 2020
  • Growth Opportunity 3: Developing and Manufacturing of Biosimilars in India for the Global Market, 2020
  • Growth Opportunity 4: Interchangeability Approvals for Increased Biosimilar Uptake in the US Market, 2020
  • Growth Opportunity 5: Ophthalmology Biosimilars for First-to-Market Advantage, 2020

4. Next Steps

For more information about this report visit https://www.researchandmarkets.com/r/py3m80

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.


CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Press Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900

Primary Logo

View Comments and Join the Discussion!
 

Latest Ratings

StockFirmActionPT
HYMCBMO CapitalInitiates Coverage On
DEMorgan StanleyMaintains335.0
SBNYRaymond JamesMaintains138.0
CORTHC Wainwright & Co.Maintains32.0
CYBBFCitigroupDowngrades
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com